Supplementary Material to Histopathologic regression in patients with primary cutaneous melanoma undergoing SLNB
Published: 16 November 2023| Version 1 | DOI: 10.17632/ymdnndrc6p.1
Contributor:
Nikolaus WagnerDescription
Supplementary Figures and Tables to the Original Article: "Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single institutional cohort study"
Files
Institutions
Universitatsklinikum Tubingen Universitats-Hautklinik Tubingen
Categories
Dermatology, Chemotherapy, Skin, Metastasis, Histopathology, Melanoma, Targeted Therapy, Immune Checkpoint Blockade, Skin Cancer Survival, Immune Checkpoint Inhibitor